Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2003 | 01-2003 | 10-2002 | 07-2002 | 04-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 195 | 196 | 296 | 400 | 449 |
| Receivables | N/A | 0 | 5 | N/A | N/A |
| Inventories | 24 | 24 | 25 | 29 | 26 |
| TOTAL | $230 | $237 | $342 | $442 | $489 |
| Non-Current Assets | |||||
| PPE Net | 246 | 260 | 271 | 279 | 286 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $258 | $271 | $282 | $290 | $297 |
| Total Assets | $487 | $508 | $624 | $732 | $786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 65 | 35 | 89 | 137 | 88 |
| TOTAL | $693 | $649 | $658 | $801 | $784 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 4 | 4 | 94 | 129 |
| TOTAL | $4 | $4 | $5 | $6 | $7 |
| Total Liabilities | $697 | $653 | $663 | $807 | $791 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 709 | 709 | 709 | 709 | 709 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -6,147 | -6,082 | -5,976 | -6,013 | -5,937 |
| Other shareholders' equity | 0 | 531 | 531 | 531 | 531 |
| TOTAL | $-210 | $-145 | $-39 | $-76 | $-5 |
| Total Liabilities And Equity | $487 | $508 | $624 | $732 | $786 |